
Conditions: Advanced Solid Tumors
Interventions: Drug: SHR-7631
Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Not yet recruiting
Conditions: Advanced Solid Tumors
Interventions: Drug: SHR-7631
Sponsors: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Not yet recruiting
Introduction Melasma is a common skin condition that can be difficult to treat. A commonly used treatment is Hydroquinone at 4%, but it may have side effects. Study Objective This…
“`html Study Summary: Impact of Allogeneic Hematopoietic Cell Transplantation on Patients with FLT3-ITDmut+ AML Background Allogeneic hematopoietic cell transplantation (alloHCT) is used to treat patients with acute myeloid leukemia (AML)…
Understanding Depression Monitoring in Clinical Trials Objective of the Study This study examined how two methods of measuring depression—Ecological Momentary Assessment (EMA) and Weekly Questionnaires (WQA)—compare in clinical trials. We…
Study Overview This study focused on multiple sclerosis (MS), a chronic condition that creates caregiving challenges. It aimed to evaluate how a patient-centered empowerment program using telenursing could help individuals…
Study Results: What Worked and What Didn’t The study tested a new tool called the Fatigue Differential Diagnostic Aid (FDDA) to help doctors understand and manage unexplained fatigue in patients.…
“`html Study Summary Cardiovascular disease is a major cause of death and illness globally, especially in people at high risk. The Hjerteløftet Study showed that a 36-month primary prevention program…